HORIBA to Exhibit the Microsemi CRP Haematology Analyser at Pulse Live 2013 Event
Hilton Birmingham Metropole Hotel, Birmingham, 30 April – 1 May
The Microsemi CRP haematology analyser
Northampton, UKÂ – HORIBA UK Ltd, Medical Division, specialists in automated in vitro diagnostic systems for haematology and chemistry analysis, will be exhibiting the Microsemi CRP haematology analyser at the Pulse Live event taking place at the Hilton Birmingham Metropole Hotel from 30 April – 1 May.
The Microsemi CRP haematology analyser was developed by HORIBA Medical in Japan, 'emi' means 'smile' in Japanese and stands for easy to use, maintenance free and intelligent. This compact, easy-to-use addition to the Micros range simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18 ìl of blood - all in just 4 minutes.
Delegates at the two day event, including GPs, practice managers and primary care managers, will be able to see for themselves how the Microsemi CRP provides information of great clinical value enabling quicker and more accurate medical decisions to ultimately reduce costs and improve the patient pathway.
Its rapid and accurate CRP analysis, coupled with a blood count, allows the screening of patient samples to detect the presence of inflammation caused by bacterial infections, or other treatable inflammatory disease. Measurement is possible immediately after blood sample collection, making this analyser the ideal choice for urgent testing situations. The Microsemi CRP can also be used to assess infection and inflammatory conditions that require progressive observation.
The Pulse Live event will also provide GPs with opportunities to hone their skills in practice business and finance, find out the latest in key clinical topics and share best practice across a variety of issues.
For more information please visit www.horiba.com/uk/medical
ABOUT HORIBA UK Ltd – Medical Division:
www.horiba.com/uk/medical
Resulting from nearly 30 years of understanding and meeting its customers’ exacting individual needs, the HORIBA UK Ltd Medical team holds a wealth of expertise in haematology, and increasingly, in clinical chemistry. Consequently, HORIBA UK Ltd - Medical has become a well-respected and renowned specialist in the design and manufacture of automated in vitro diagnostic systems for haematology and chemistry analysis.
HORIBA UK Ltd - Medical now facilitates the entire haematology process, both in the laboratory and at the point of care, from process and analyser optimisation, analysing samples and managing data, including new computer-assisted microscopy options, through to remote monitoring and e-Learning. Furthermore, in addition to NHS and private healthcare settings, HORIBA Medical products are proving their worth in many other areas, including: veterinary diagnostics, sports science, food and beverage, pharma and nutraceuticals, and clinical research.
From compact to high throughput systems, HORIBA UK Ltd - Medical continues to successfully evolve, develop and deliver an array of analysers and reagents, as well as data management solutions to meet all needs, enabling LEAN analysis anywhere it is required. Indeed, through its commitment to providing the most comprehensive haematology portfolio available, 2013 will see the launch of a number of new products. These are all designed to provide the best possible solutions within a fast changing IVD world.
HORIBA UK Ltd - Medical’s product and service combinations all deliver quality results, flexibility, security and process efficiency. These merits in turn ensure effective clinical decision making, enhanced patient care pathways and improved patient outcomes.
Ref 1306HMED
Product Enquiries
HORIBA UK Ltd, Medical Division
Tanya Johnstone
t: +44 (0)1604 542650Â Â Â Â Â Â
e: info@horiba.com
w: www.horiba.com/uk/medical
